ARCHIVES

Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Diane Fink Accepts VP Job With ACS

April 3, 1981

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980